|
DOID:0050884
|
triosephosphate isomerase deficiency
|
SGD:S000002457
|
Saccharomyces cerevisiae S288C
|
851620
|
TPI1
|
|
genetic interaction evidence used in manual assertion
|
|
|
DOID:0050884
|
triosephosphate isomerase deficiency
|
SGD:S000002457
|
Saccharomyces cerevisiae S288C
|
851620
|
TPI1
|
|
sequence similarity evidence used in manual assertion
|
|
|
DOID:162
|
cancer
|
SGD:S000002457
|
Saccharomyces cerevisiae S288C
|
851620
|
TPI1
|
|
genetic interaction evidence used in manual assertion
|
|
|
DOID:162
|
cancer
|
SGD:S000002457
|
Saccharomyces cerevisiae S288C
|
851620
|
TPI1
|
|
sequence similarity evidence used in manual assertion
|
|
|
DOID:3070
|
high grade glioma
|
SGD:S000002224
|
Saccharomyces cerevisiae S288C
|
851493
|
IDP1
|
|
sequence similarity evidence used in manual assertion
|
|
|
DOID:3070
|
high grade glioma
|
SGD:S000002224
|
Saccharomyces cerevisiae S288C
|
851493
|
IDP1
|
|
mutant phenotype evidence used in manual assertion
|
|
|
DOID:0060559
|
lethal congenital contracture syndrome 1
|
SGD:S000002366
|
Saccharomyces cerevisiae S288C
|
851320
|
GLE1
|
|
sequence similarity evidence used in manual assertion
|
|
|
DOID:0060559
|
lethal congenital contracture syndrome 1
|
SGD:S000002366
|
Saccharomyces cerevisiae S288C
|
851320
|
GLE1
|
|
genetic interaction evidence used in manual assertion
|
|
|
DOID:1289
|
neurodegenerative disease
|
SGD:S000004295
|
Saccharomyces cerevisiae S288C
|
851013
|
ACO1
|
|
genetic interaction evidence used in manual assertion
|
|
|
DOID:331
|
central nervous system disease
|
SGD:S000004295
|
Saccharomyces cerevisiae S288C
|
851013
|
ACO1
|
|
sequence similarity evidence used in manual assertion
|
|
|
DOID:1289
|
neurodegenerative disease
|
SGD:S000004295
|
Saccharomyces cerevisiae S288C
|
851013
|
ACO1
|
|
sequence similarity evidence used in manual assertion
|
|
|
DOID:1891
|
optic nerve disease
|
SGD:S000004295
|
Saccharomyces cerevisiae S288C
|
851013
|
ACO1
|
|
sequence similarity evidence used in manual assertion
|
|
|
DOID:0111442
|
optic atrophy 9
|
SGD:S000004295
|
Saccharomyces cerevisiae S288C
|
851013
|
ACO1
|
|
sequence similarity evidence used in manual assertion
|
|
|
DOID:331
|
central nervous system disease
|
SGD:S000004295
|
Saccharomyces cerevisiae S288C
|
851013
|
ACO1
|
|
genetic interaction evidence used in manual assertion
|
|
|
DOID:0111442
|
optic atrophy 9
|
SGD:S000004295
|
Saccharomyces cerevisiae S288C
|
851013
|
ACO1
|
|
mutant phenotype evidence used in manual assertion
|
|
|
DOID:1891
|
optic nerve disease
|
SGD:S000004295
|
Saccharomyces cerevisiae S288C
|
851013
|
ACO1
|
|
genetic interaction evidence used in manual assertion
|
|
|
DOID:0080417
|
developmental and epileptic encephalopathy 38
|
SGD:S000004232
|
Saccharomyces cerevisiae S288C
|
850943
|
ARV1
|
|
mutant phenotype evidence used in manual assertion
|
- PMID:32449190
- PMID:32462292
|
|
DOID:9455
|
lipid storage disease
|
SGD:S000004232
|
Saccharomyces cerevisiae S288C
|
850943
|
ARV1
|
|
genetic interaction evidence used in manual assertion
|
|
|
DOID:0080417
|
developmental and epileptic encephalopathy 38
|
SGD:S000004232
|
Saccharomyces cerevisiae S288C
|
850943
|
ARV1
|
|
sequence similarity evidence used in manual assertion
|
- PMID:27270415
- PMID:32165008
- PMID:32449190
- PMID:32462292
|
|
DOID:0080417
|
developmental and epileptic encephalopathy 38
|
SGD:S000004232
|
Saccharomyces cerevisiae S288C
|
850943
|
ARV1
|
|
genetic interaction evidence used in manual assertion
|
|
|
DOID:9455
|
lipid storage disease
|
SGD:S000004232
|
Saccharomyces cerevisiae S288C
|
850943
|
ARV1
|
|
sequence similarity evidence used in manual assertion
|
|
|
DOID:3070
|
high grade glioma
|
SGD:S000004164
|
Saccharomyces cerevisiae S288C
|
850871
|
IDP2
|
|
mutant phenotype evidence used in manual assertion
|
|
|
DOID:3070
|
high grade glioma
|
SGD:S000004164
|
Saccharomyces cerevisiae S288C
|
850871
|
IDP2
|
|
sequence similarity evidence used in manual assertion
|
|
|
DOID:0080552
|
congenital disorder of glycosylation Ia
|
SGD:S000001849
|
Saccharomyces cerevisiae S288C
|
850499
|
SEC53
|
|
mutant phenotype evidence used in manual assertion
|
|
|
DOID:0080552
|
congenital disorder of glycosylation Ia
|
SGD:S000001849
|
Saccharomyces cerevisiae S288C
|
850499
|
SEC53
|
|
genetic interaction evidence used in manual assertion
|
|